STOCK TITAN

HeartFlow Holding, Inc. to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

HeartFlow, a leader in precision heart care, will participate in two virtual investor conferences: the Stifel Healthcare Conference on November 17, 2021, featuring a Fireside Chat at 1:20 pm ET, and the Canaccord Genuity MedTech Forum on November 18, 2021, with 1x1 meetings. Investors can access the Fireside Chat via the company’s website. HeartFlow's innovative technology utilizes AI for non-invasive heart assessments and is available in major markets, including the US, UK, Canada, Europe, and Japan.

Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- HeartFlow Holding, Inc., the leader in revolutionizing precision heart care, today announced the company will be participating in two upcoming virtual investor conferences.

Event: Stifel 2021 Healthcare Conference
Format: Fireside Chat and 1x1 Meetings
Date: Wednesday, November 17, 2021
Presentation time: 1:20 pm ET / 10:20 am PT

Interested investors may access a live and archived webcast of the Fireside Chat on the “Investors” section of the company website at: http://www.heartflow.com/investors/

Event: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Format: 1x1 Meetings
Date: Thursday, November 18, 2021

Due to the format of this event, no webcast is available.

About HeartFlow
HeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow’s non-invasive HeartFlow FFRct Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRct Analysis is commercially available in the United States, UK, Canada, Europe and Japan. For more information, visit www.heartflow.com.

Contacts:
For Investors:
Leigh Salvo or Jack Droogan
Gilmartin Group        
Investors@heartflow.com

For Media:
Jennie Kim
HeartFlow
media@heartflow.com


FAQ

What conferences is HeartFlow participating in November 2021?

HeartFlow is participating in the Stifel Healthcare Conference on November 17, 2021, and the Canaccord Genuity MedTech Forum on November 18, 2021.

What time is the Fireside Chat at the Stifel Conference?

The Fireside Chat at the Stifel Healthcare Conference is scheduled for November 17, 2021, at 1:20 pm ET.

How can investors access the Fireside Chat?

Investors can access the live and archived webcast of the Fireside Chat through the Investors section of HeartFlow's website.

Is there a webcast for the Canaccord Genuity MedTech Forum?

No, there is no webcast available for the Canaccord Genuity MedTech Forum as it will only feature 1x1 meetings.

What does HeartFlow's technology involve?

HeartFlow's technology includes a non-invasive HeartFlow FFRct Analysis that uses AI to create a personalized 3D model of the heart to assess blood flow impact from blockages.

HFLO

:HFLO

HFLO Rankings

HFLO Latest News

HFLO Stock Data